Technology · 09/10/2026

European Medicines Agency Approves Modification to Paediatric Investigation Plan for Enerzair Breezhaler

The European Medicines Agency has issued an opinion and decision on a modification to the Paediatric Investigation Plan for Enerzair Breezhaler, a respiratory medication, following a request from the manufacturer to update the plan.